Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Filamon LTD
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Hoffmann-La Roche
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Arvinas Inc.